In vivo biodistribution of radiolabeled MMP‐2/9 activatable cell‐penetrating peptide probes in tumor‐bearing mice

By  

CONTRAST MEDIA & MOLECULAR IMAGING (ELECTRONIC), Vol. 10, Iss. 1, 2015-01 ,pp. : 59-66

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Dose-Escalation Study of Pegylated Liposomal Doxorubicin and Oxaliplatin in Patients with Advanced Solid Tumors

By  

Oncology, Vol. 71, Iss. 3-4, 2007-07 ,pp. : 190-196

Karger

Access to resources Recommend Favorite

A Dose Escalation Study of Pegylated Liposomal Doxorubicin (Caelyx) in Combination with Capecitabine (Xeloda) in Patients with Refractory Solid Tumors

By  

Oncology, Vol. 69, Iss. 6, 2006-02 ,pp. : 463-469

Karger

Access to resources Recommend Favorite

Enhanced binding and killing of target tumor cells by drug-loaded liposomes modified with tumor-specific phage fusion coat protein

By Wang Tao   D’Souza Gerard GM   Bedi Deepa   Fagbohun Olusegun A   Potturi L Prasanna   Papahadjopoulos-Sternberg Brigitte   Petrenko Valery A   Torchilin Vladimir P  

Nanomedicine, Vol. 5, Iss. 4, 2010-06 ,pp. : 563-574

Future Medicine

Access to resources Recommend Favorite

Chitosan derivative nanocarrier: Safety evaluation, antibacterial property and ascorbyl palmitate encapsulation

By Wittayasuporn Mayura   Rengpipat Sirirat   Palaga Tanapat   Asawanonda Pravit   Anumansirikul Nattaporn   Wanichwecharungruang Supasorn P.  

Journal of Microencapsulation, Vol. 27, Iss. 3, 2010-05 ,pp. : 218-225

Informa Healthcare

Access to resources Recommend Favorite